HSA — authorised 24 February 1960
- Marketing authorisation holder: VALEANT PHARM INTL
- Status: likely_approved
HSA authorised Chlordiazepoxide Hydrochloride on 24 February 1960
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 24 February 1960.
VALEANT PHARM INTL holds the Singaporean marketing authorisation.